RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments
Quteineh, L., Vandenberghe, F., Saigi Morgui, N., Delacrétaz, A., Choong, E., Gholam-rezaee, M., Magistretti, P., Bondolfi, G., Von Gunten, A., Preisig, M., Castelao, E., Vollenweider, P., Waeber, G., Bochud, M., Kutalik, Z., Conus, P., & Eap, C. B. (2015). Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. Pharmacogenetics and Genomics, 25(5), 246-258. https://doi.org/10.1097/FPC.0000000000000131
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.